Myth: Alternative nicotine products don't help people stop smoking: Difference between revisions
Jump to navigation
Jump to search
| Line 92: | Line 92: | ||
*Changes in prevalence of e-cigarette use in England have been positively associated with the success rates of quit attempts. No clear association has been found between e-cigarette use and the rate of quit attempts or the use of other quitting aids, except for NRT obtained on prescription, where the association has been negative. | *Changes in prevalence of e-cigarette use in England have been positively associated with the success rates of quit attempts. No clear association has been found between e-cigarette use and the rate of quit attempts or the use of other quitting aids, except for NRT obtained on prescription, where the association has been negative. | ||
*[https://www.bmj.com/content/bmj/354/bmj.i4645.full.pdf PDF Version] | *[https://www.bmj.com/content/bmj/354/bmj.i4645.full.pdf PDF Version] | ||
===2016: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896829/ Patterns of Electronic Cigarette Use Among Adults in the United States]=== | |||
*Results: Current e-cigarette use is extremely low among never cigarette smokers (0.4%) and former smokers who quit cigarettes 4 or more years ago (0.8%). Although e-cigarette experimentation is most common among current cigarette smokers and young adults, daily use is highest among former smokers who quit in the past year (13.0%) and older adults. Compared to daily cigarette smokers, recently quit smokers were more than four times as likely to be daily users of e-cigarettes. | |||
*Conclusion: Extremely low e-cigarette use among never-smokers and longer term former smokers suggest that e-cigarettes neither promote widespread initiation nor relapse among adults. Recognition of the heterogeneity of smokers, including the time since quitting, is critical to draw accurate conclusions about patterns of e-cigarette use at the population level and its potential for public health benefit or harm. | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896829/pdf/ntv237.pdf PDF Version] | |||
<br> | <br> | ||